Standard BioTools (LAB) announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with SomaLogic (SLGC) at its Special Meeting of Stockholders. The merger is expected to close on January 5, 2024, subject to satisfaction of certain customary closing conditions.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LAB:
- Standard BioTools Stockholders Approve Merger with SomaLogic
- SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting
- Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
- SomaLogic announces Glass Lewis, ISS recommendation for Standard BioTools merger
- SomaLogic sent letter to stockholders on transaction with Standard BioTools